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Epidermolysis bullosa simplex (EBS) is caused by
defective assembly of keratin intermediate filaments
in basal keratinocytes and recent studies indicated
causal mutations in the keratin KRT5 and KRT14
genes. In this study, we describe a novel KRT5 muta-
tion in a German sporadic case of EBS Dowling–
Meara. Transition of G to T (nucleotide position 2334)
leads to a premature stop codon (E477stop, residue 93
Epidermolysis bullosa simplex (EBS) is a group of heredit-ary skin disorders with mostly autosomal dominantinheritance, characterized by intraepidermal blisterformation due to cytolysis of basal keratinocytes afterminor mechanical stress. Blistering is more frequent in
warm and humid weather and generally improves with advancing
age. Epidermolysis bullosa herpetiformis Dowling–Meara (EBS-
DM) is the most severe subtype of EBS, characterized by extensive
blistering since birth with herpetiform marginal spreading and
central healing, leaving light-brown postbullous pigmentations. Oral
mucosal involvement, nail dystrophy, onychogryposis, formation of
milia, and palmoplantar hyperkeratosis are common features
(Anton-Lamprecht and Schnyder, 1982; Fine et al, 1991; Gedde-
Dahl and Anton-Lamprecht, 1996). In contrast to the milder forms
of EBS, skin biopsies of EBS-DM reveal distinctive ultrastructural
abnormalities: aggregation and clumping of basal keratins resulting
in a total collapse of the keratin cytoskeleton of basal keratinocytes
(Anton-Lamprecht and Schnyder, 1982; Anton-Lamprecht, 1983,
1992).
In 1991, Vassar et al (1991) showed that expression of a truncated
K14 gene in transgenic mice led to clinical and morphologic
findings resembling EBS-DM. Subsequent sequence analysis of
keratin genes in EBS patients revealed that point mutations in the
basal keratins K5 and K14 are clustered in distinct regions of the
central rod domain (for review see Corden and McLean, 1996;
Fuchs, 1996; Korge and Krieg, 1996; Paller, 1996). Almost all
EBS-DM mutations are located in the highly conserved hydrophilic
peptides of either the amino or the carboxy end of the central α-
helical rod domain with the majority of mutations residing either
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of the 2B helix) in the last residue of the highly
conserved helix-termination peptide K/LLEGE of the
2B rod domain of keratin K5. This represents the first
premature stop codon mutation identified within the
K/LLEGE motif of any disorder reported so far that
is caused by keratin mutations. Key words: epidermolysis
bullosa simplex/intermediate filaments/keratin genes. J Invest
Dermatol 112:988–990, 1999
in the 1A helix initiation peptide of K14 or in the 2B helix
termination peptide of K5. Here we report a novel K5 mutation
(E477stop, residue 93 of the 2B helix, the last residue of the K/
LLEGE motif) in a patient showing the characteristic clinical and
ultrastructural features of EBS-DM. The location of this K5
mutation is consistent with previous reports but also provides
additional in vivo evidence that partial K/LLEGE truncation of K5
indeed disturbs normal K5/K14 keratin filament assembly, which
is in agreement with the in vitro assembly studies by Wilson
et al (1992).
MATERIALS AND METHODS
Case report (Fig 1) A 38 y old woman was affected since birth by
generalized blister formation with herpetiform spreading and central healing,
leaving faint brown postbullous pigmentations. Hemorrhagic blisters
occurred on trunk and extremities including palms and soles, on the face,
and on the oral mucosa after minor trauma. Some improvement was noted
after the fourth year of life. Palmar and plantar hyperkeratoses were
reported to have existed already before walking and often caused painful
problems in periods of plantar blistering. Subungual blisters and irregular
nail plate thickening were present, and the patient experienced recurrent
generalized blistering even in adulthood. The diagnosis of the Dowling–
Meara type was stated by electron microscopy of a skin biopsy sample at
the age of 19 and confirmed clinically some time later on clinical inspection
in Heidelberg. As no other family member is affected, she represents a
spontaneous new DM mutation. Her son is unaffected.
Electron microscopy A 1 d old blister induced experimentally by
friction by the patient, had been excised elsewhere for electron microscopy
at the age of 19 y. The sample was subdivided prior to fixation, then fixed
in phosphate-buffered 2.5% glutaraldehyde solution, dehydrated in graded
ethanols, and embedded in Durcupan. Cured tissue blocks were later sent
to Heidelberg for electron microscopic analysis and diagnosis. Ultrathin
sections were investigated using a Philips EM 400 electron microscope.
Mutation detection Genomic DNA isolated from ethylenediamine
tetraacetic acid blood samples was used to amplify exon 7 of KRT5 by
polymerase chain reaction (Taq DNA polymerase, Boehringer, Mannheim,
Germany). The primer set was 59 CCC ACT CTC CTC CTT TCT
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Figure 1. Pedigree of the EBS-DM case. Family members analyzed
are indicated by numbers.
ATC 39 and 59 CGC TTT ATC AAC TGA AGG CC 39. A 50 µl reaction
solution containing 250 ng DNA, 200 nM of each primer, 200 µM of
each dNTP, 10 mM Tris–HCl, 1.25 U Taq DNA polymerase with
optimized pH, MgCl2 and KCl concentrations were initially denaturated
at 94°C for 2 min, followed by 35 cycles of 1 min at 94°C, 1 min at 56°C
and 1.5 min at 72°C, followed by a 7 min final extension step at 72°C.
Direct sequencing of polymerase chain reaction products was preceded by
shrimp alkaline phosphatase and exonuclease 1 treatment (Sequenase PCR
product sequencing kit, USB/Amersham Life Science, Cleveland, OH) as
described (Mu¨ller et al, 1998). An additional sequencing primer was 59
CAA GCA GGA CAT GGC CCG 39.
RESULTS
Skin ultrastructure Advanced blister formation with partial or
complete destruction of basal cells, small intrabasal blisters, and
exocytosis of lymphocytes were seen in the blister area. Most
affected basal cells were necrotic. In the upper dermis, increased
numbers of small capillaries, a lymphohistiocytic infiltrate, and
pigment-loaded melanophages reflected the intense inflammatory
reaction to blister formation. In less destroyed areas and adjacent
to the blister basal cells revealed round or irregular clumps and
aggregation of their keratin filaments as a result of a collapse of the
entire basal keratin network. Most of the clumps were distributed
irregularly in the cytoplasm that otherwise was entirely normal,
and only few of them were attached to desmosomes (Fig 2). Upper
epidermal keratinocytes were normal apart from some unspecific
high-level paranuclear vacuoles due to friction. Clumping of basal
keratins is unique among EBS subtypes and pathognomonic of the
DM type, thus permitting the diagnosis of EBS-DM for the patient.
Mutation analysis The entire H1, 1A, and 2B domains of
keratin K5 and K14 were screened for potential mutations (Fig 3).
The sequence analysis detected a G to T transition at base 2334
(EMBL accession code: M28496) in residue 93 of the 2B helix of
KRT5 leading to an exchange of a glutamic acid to a stop codon
at position 477 of K5 (2B rod domain position 93, the last residue
of the K/LLEGE motif). This premature stop codon results in a
truncated K5 protein lacking the last four amino acid residues of
the helix termination peptide (residues 477–480) and the entire tail
domain. The parents, the two sisters, and the son of the patient,
who were all clinically unaffected, did not show the mutation and
neither did 23 normal nonrelated controls.
DISCUSSION
EBS-DM mutations are generally located in the highly conserved
hydrophilic residues of either end of the central α-helix, mainly in
the helix termination peptide of K5 or in the helix initiation
peptide of K14. Previously, two stop codon mutations were also
reported in the 1A/1B region of K14 in two patients with autosomal
recessive EBS (Chan et al, 1994; Rugg et al, 1994). In these
Figure 2. Electron microscopy. Part of a basal cell with clumping of
the keratin network: keratin clumps (asterisks) are rounded or irregular in
shape and only partly connected to desmosomes; the remainder of the
cytoplasm with nucleus (N), mitochondria (M), ER cisternae, and melanin
granules is ultrastructurally normal, although devoid of a normal keratin
cytoskeleton. Final magnification, 317600; scale bar: 1 µm.
Figure 3. Mutation E477stop. Part of the DNA sequencing gel showing
the point mutation detected in the helix termination peptide of K5.
Sequences of the patient (A) and an unaffected family member (U) are
shown. Arrow indicates the location of the mutation.
mutations the truncated K14 proteins as well as the corresponding
mRNA are obviously unstable, which results in a functional K14
knockout in homozygous individuals. In heterozygous individuals
the defects can be compensated by the remaining unaffected K14
gene. In contrast, the stop codon mutation in K5 found in our
autosomal dominant case most probably leads to a stable truncated
protein which participated in intermediate filament formation. This
notion is supported by our electron microscopic data, revealing in
our patient the basal clumping of keratins which is characteristic
for EBS-DM, while basal keratins were missing in both cases of
K14. How the defective keratins impair normal keratin intermediate
filament (KIF) stability is still speculative. Several lines of experi-
mental evidence suggest that the mutation described here will alter
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various stages of KIF formation and help to understand the rather
severe clinical phenotype of our patient.
The basic feature of intermediate filaments including keratins is
the periodicity of heptad repeats in the central α-helix, which
allows to form a coiled-coil dimer (Cohen and Parry, 1986). The
residues in the a and d position are mostly occupied by apolar
amino acids which form a hydrophobic core between interacting
coiled-coil molecules. Oppositely charged residues in the e and g
position are able to stabilize the coiled-coil by forming salt bridges
(Conway and Parry, 1990). Site-directed mutagenesis of the d
position at the end of the 2B rod domain of K8/K18 caused the
heptad structure to dissolve and perturbed heterodimer formation
in vitro (Hatzfeld and Weber, 1990). Based on these observations
the occurrence of a premature stop codon mutation in the d
position of the K5 helix termination peptide as reported here
is therefore likely to destabilize the formation of coiled-coil
heterodimers.
Further experimental support for this notion was given by
Hatzfeld and Weber (1991) in using a competing synthetic peptide
representing the K/LLEGE consensus sequence; this caused disas-
sembly of preformed KIF in vitro suggesting that this motif may be
crucial for alignment of tetramers during elongation and protofibril
formation. Additional in vitro assembly studies by Wilson et al
(1992), who paired wild-type K14 chains with mutant K5 chains
lacking the entire tail domain in addition to the K/LLEGE
motif resulted in substantially fewer, shorter, and thicker filaments
compared with wild-type filaments. It remains to be discussed, to
what extent the additional absence of the H2 domain in our patient
contributes to the severity of the disease phenotype.
This aspect was partly addressed in in vitro assembly studies with
mutant truncated K5 chains lacking the entire tail domain plus the
last residue of the 2B rod domain: electron micrographs revealed
slightly shorter than normal filaments which had the tendency to
associate laterally into cables of two or three intertwined filaments
(Wilson et al, 1992). The fact that the amino acid sequence of the
H2 peptide has also been highly conserved might implicate an
additional obligatory role of the H2 peptide in KIF assembly and
stabilization.
The present model of KIF structure postulates linear arrays of
keratin heterodimers (Steinert et al, 1993). The beginning of the
1A rod domain of one dimer is connected by a 10–11 residue
head-to-tail overlap to the 2B end of the next dimer in line. These
overlap regions correspond exactly to those locations where keratin
mutations occur in EBS-DM patients. Therefore, the model might
explain the high evolutionary conservation of these sequences at
both ends of the rod domain in all intermediate filaments and the
deleterious effect of these mutations for higher order filament
formation, elongation, and stability.
Transgenic mice expressing a truncated K14 with lack of the last
third of the C-terminal rod domain produce a severe EBS-DM
phenotype leading to early neonatal death (Vassar et al, 1991). The
K5 truncation at the very end of the C-terminal rod in our case is
nonlethal in humans but may explain the rather severe clinical
phenotype with lack of improvement with advancing age.
The mutation reported here affects the same codon as a previously
described recurrent point mutation (G/A2334 substitution, E477K)
in sporadic EBS-DM cases (Stephens et al, 1997) who presented
with the typical clinical EBS-DM phenotype and keratin clumping
in basal keratinocytes. The frequency of sporadic mutations at
this position is likely due to a common mechanism for human
mutagenesis involving spontaneous deamination of a methylated
cytidine residue in a CpG dinucleotide (Cooper and Youssoufian,
1988). The CpG site in nucleotide position 2333/2334 of KRT5
can therefore be considered as a mutational hot spot for EBS-
DM. This common mechanism gets further support from several
mutations in the corresponding residue of keratin 2e in ichthyosis
bullosa of Siemens (Kremer et al, 1994; McLean et al, 1994;
Rothnagel et al, 1994; Jones et al, 1997) and of the basic hair
keratins 1 and 6 in monilethrix (Winter et al, 1997a; 1997b; Korge
et al, 1998).
It will be of interest for the future whether corresponding
mutations can be found in other disorders caused by keratin defects.
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